Introduction {#sec1}
============

Pyrrolo\[2,1-*a*\]isoquinoline and 5,6-dihydropyrrolo\[2,1-*a*\]isoquinoline represent the core structure of lamellarin-type alkaloids and various bioactive compounds displaying a wide spectrum of biological activities ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref1]^ For instance, Lamellarin I has multidrug-resistant reversal activity at nontoxic doses, whereas Lamellarin K is cytotoxic to different cancer cell lines.^[@ref2]^ Lamellarin K and L are reported to have immunomodulatory activity in the micromolar range.^[@ref3]^ Furthermore, Lamellarin D is cited to be a potent inhibitor of DNA topoisomerase I,^[@cit4a]^ whereas Lamellarin α-20-sulfate is a selective inhibitor of HIV-1 integrase.^[@cit4b]^

![Representative examples of bioactive compounds having pyrrolo\[2,1-*a*\]isoquinoline and 5,6-dihydropyrrolo\[2,1-*a*\]isoquinoline frameworks.](ao9b03546_0013){#fig1}

Given the diverse biological properties, synthetic chemists have formulated several elegant strategies for constructing differently substituted pyrrolo\[2,1-*a*\]isoquinoline cores.^[@ref5]^ Recently, we have reported the dehydrative transformation of spirooxindoles to pyrido\[2,3-*b*\]indoles in the presence of POCl~3~.^[@ref6]^ The reaction could be performed as a one-pot two-step process. However, our attempts to prepare the spirooxindole **4** by reacting isatin (**1a**) with 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (**2**) and phenyl acetylene (**3a**) as reported were unsuccessful.^[@ref7]^ After a short screening for identifying conditions to access **4**, we were successful in synthesizing it under microwave irradiation albeit in only 5% yield ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). It was reported the reaction between isatin (**1a**), 1,2,3,4-tetrahydroisoquinoline (THIQ) (**5a**), and alkenes in the presence of trifluoroacetic acid (TFA) in toluene or montmorillonite K10 leads to the formation of spirooxindoles.^[@ref8]^ Notably, however, the fate of this multicomponent reaction (MCR) using terminal alkynes instead of alkenes remains unknown, though it could be reasoned that such a reaction should also afford a spirooxindole (**6**). As a consequence, we considered investigating the MCR between isatin, THIQ, and terminal alkyne in the presence of an acid catalyst. Accordingly, the reaction between **1a**, **3a**, and **5a** in the presence of TFA in toluene as the medium at 50 °C was attempted. We found that the reaction was incomplete even after 12 h, but post-workup at this stage, the major isolated product (34%) was established as *N*-(2-(2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide **7aaa** instead of the spirooxindole **6** ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). This result suggested consumption of 2.0 equiv of **5a**, and therefore we repeated the reaction with 2.0 equiv of THIQ, and it was pleasing to discover that the reaction was completed in 22 h to afford **7aaa** in 72% yield. Earlier, Stoltz et al. reported a base-mediated skeletal rearrangement (C2--C3 bond cleavage) of substituted oxindole to offer a urea derivative via intermediacy of isocyanate.^[@ref9]^ However, the propensity of the protocol to afford 5,6-dihydropyrrolo\[2,1-*a*\]isoquinolines incorporating the urea moiety directly via an acid-catalyzed MCR between isatin, THIQ, and terminal alkyne together with lack of too many reports^[@ref10]^ on C2--C3 bond cleavage of oxindoles evoked us to investigate the reaction comprehensively.

![Proposed Route for the Synthesis of Spirooxindole **4**](ao9b03546_0011){#sch1}

![Comparison of This Work with the Reported Work](ao9b03546_0008){#sch2}

Herein, we report the details of the results of our study and the scope of this MCR.

Results and Discussion {#sec2}
======================

At the outset of the study, we considered optimizing the reaction condition for the formation of product **7**, and the results are summarized in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}. As stated above, performing the reaction of **1a** and **3a** with 2.0 equiv of **5a** in TFA as the medium at 50 °C resulted in the formation of **7aaa** in 72% yield (entry 1). Increasing the temperature of the reaction to 80 °C produced **7aaa** in 81% isolated yield within 18 h (entry 2). Next, to investigate the effect of different acid catalysts, the reaction was carried out in the presence of AcOH, benzoic acid, or *p*-TSA, and it was found that benzoic acid gave **7aaa** in a superior yield (84%) (entries 3--5). We discovered that this reaction was successful even in the absence of acid to furnish **7aaa** in 71% yield in 26 h (entry 6). Probe for identifying a suitable solvent for the reaction revealed that it was successful in MeCN, dioxane, 1,2-dichloroethane (DCE), and water but, the best yield of **7aaa** was obtained in toluene (entries 7--10). Optimization with respect to reaction temperature identified 90 °C to be the most suited for the formation of **7aaa** (86%) (entry 11). Therefore, the optimized conditions for the synthesis of 5,6-dihydro-pyrrolo\[2,1-*a*\]isoquinoline **7aaa** were identified as heating isatin **1a** (1.0 equiv), THIQ **5a** (2.0 equiv), and terminal alkyne **3a** (1.0 equiv) in the presence of 20 mol % benzoic acid in toluene at 90 °C for 16 h.

###### Results of the Optimization Study[a](#t1fn1){ref-type="table-fn"}

![](ao9b03546_0012){#gr12}

  entry   acid catalyst (20 mol %)   solvent   temp (°C)   time (h)   yield (%)[b](#t1fn2){ref-type="table-fn"} of **7aaa**
  ------- -------------------------- --------- ----------- ---------- -------------------------------------------------------
  1       TFA                        toluene   50          22         72
  2       TFA                        toluene   80          18         81
  3       AcOH                       toluene   80          18         77
  4       PhCO~2~H                   toluene   80          18         84
  5       *p*-TSA                    toluene   80          18         79
  6       \-                         toluene   80          26         71
  7       PhCO~2~H                   MeCN      80          20         79
  8       PhCO~2~H                   dioxane   80          24         72
  9       PhCO~2~H                   DCE       80          22         75
  10      PhCO~2~H                   H~2~O     80          24         66
  11      PhCO~2~H                   toluene   90          16         86
  12      PhCO~2~H                   toluene   100         16         86

Reaction conditions: **1a** (0.68 mmol), **5a** (1.36 mmol), **3a** (0.68 mmol), and solvent (5 mL).

Isolated yield after column chromatography.

With optimized reaction conditions in hand, the scope of the protocol was investigated initially with respect to a variety of isatins and alkynes ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). In the first set of experiments, treating differently substituted isatins (**1b**--**i**) with THIQ (**5a**) and phenyl acetylene (**3a**) under standard conditions furnished the corresponding 5,6-dihydropyrrolo\[2,1-*a*\]isoquinolines **7baa**--**7iaa** in excellent yields. The electronic character of the substituents on isatin did not influence the formation of products. The X-ray crystallographic analysis of one of the products **7eaa** unambiguously secured the structure as 5,6- dihydropyrrolo\[2,1-*a*\]isoquinolines. Subsequently, testing the scope of the reaction with several terminal alkynes **3b**--**3g** revealed that all substrates smoothly afforded the respective products **7aab**--**7aag** in 78--85% yields. Altering the phenyl ring with heteroaromatic rings in terminal alkynes was also found to be compatible with the protocol as the alkyne **3h** bearing pyridine and **3i** containing thiophene furnished **7aah** and **7aai** in 78 and 80% yields, respectively. Finally, the fate of the MCR using terminal alkynes bearing aliphatic groups was evaluated. The terminal alkyne **3j** bearing the cyclohexene ring gave the corresponding product **7aaj** in 74% yield, whereas aliphatic alkynes such as cyclopropylacetylene (**3k**) and trimethylsilylacetylene (**3l**) furnished **7aak** and **7aal** in moderate yields only. Next, the scope of the reaction was investigated with 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline **5b**, which furnished **7aba** in 82% yield, whereas 4,5,6,7-tetrahydrothieno\[3,2-*c*\]pyridine **5c** afforded the corresponding product **7aca** in 84% yield. Replacing isoquinoline with other secondary amine *N*-methylbenzylamine **5d** however failed to offer the desired product **7ada**. The activated alkyne like methyl propiolate (**3m**) and the internal alkyne dimethyl acetylenedicarboxylate (**3n**) were however discovered to offer the corresponding Michael adducts **8am** and **8an** only ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). Finally, performing the reaction between **1a**, **3a**, and **5a** at a gram scale afforded **7aaa** in 85% isolated yield, thereby indicating that the reaction can be conducted at higher scales without attenuation of the yield.

![Scope of the Reaction*^,^*\
Reaction conditions: **1** (2.04 mmol), **5** (4.08 mmol), **3** (2.04 mmol), and toluene (15 mL).\
For **1b**--**1f**, R^1^ is at C-5; for **1h**, R^1^ is at C-6; and for **1i**, R^1^ is at C-7 of isatin.](ao9b03546_0009){#sch3}

![Reaction with Activated Alkynes\
Reaction conditions: **1a** (2.04 mmol), **5a** (4.08 mmol), **3** (2.04 mmol), and toluene (15 mL).](ao9b03546_0010){#sch4}

To expand the substrate scope of the present protocol, we examined a four-component reaction (4CR) by treating isatin **1a** (1.0 equiv) with THIQ **5a** (1.0 equiv), phenyl acetylene **3a** (1.0 equiv), and aniline **9a** (1.0 equiv) under standard conditions ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}). This reaction resulted in the formation of 1-phenyl-3-(2-(2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)urea **10aaaa** (27%) together with **7aaa** (45%). The success of this 4CR to give new products invoked us to investigate a variety of amines in the protocol. The reaction with substituted anilines like 4-methylaniline (**9b**), 4-chloroaniline (**9c**), and 3-bromoaniline (**9d**) produced the desired 4CR products **10aaab**--**aaad** in 25--37% yields together with **7aaa**. However, reactions with 3-nitroaniline (**9e**), 4-aminobenzoic acid (**9f**), or *N*-Boc-1,4-phenylenediamine (**9g**) failed to afford the desired products, though the 3CR product **7aaa** (27--65%) was isolated from each reaction. The heterocyclic amine such as 8-aminoquinoline (**9h**) resulted in the formation of **10aaah** in 35% yield only along with **7aaa** in 57% yield. The reactions of 5-aminoindole (**9i**), 2-aminopyridine (**9j**), and 2-amino-5-chlorobenzothiazole (**9k**) also did not afford the respective 4CR products, but **7aaa** was isolated in 56--61% yields. Further, the scope of the reaction was investigated with aliphatic amines such as benzylamine **9l**, *N*-methylcyclohexylamine **9m**, and *N*-methylbenzylamine **5d**, and it was discovered that these reactions resulted in a complex mixture from which the required product could not be isolated. Pleasingly, however, aliphatic amines having a bulky group like 1-adamantylamine (**9n**) or *tert*-butylamine (**9o**) furnished the desired urea **10aaan** or **10aaao** in 21--43% yields together with **7aaa**.

![Scope of the Four-Component Reaction\
Reaction conditions: **1** (2.04 mmol), **5a** (2.04 mmol), **3** (2.04 mmol), **9** (2.04 mmol), and toluene (15 mL). Yields are calculated based on the amount of **5a**.](ao9b03546_0007){#sch5}

Based on the literature, we anticipated the formation of an isocyanate intermediate, but to delineate the stepwise mechanism of our reaction, we performed a few control experiments. To ascertain the essentiality of *N*-unprotected isatin for this reaction, we carried out the reaction with *N*-protected isatin **1j** under standard conditions, which resulted in a complex mixture of products ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}). In our attempt to isolate the isocyanate intermediate, the reaction between **1a**, **3a**, and **5a** was monitored carefully. The thin layer chromatography (TLC) analysis of the reaction mixture after 4 h showed the presence of two new spots beside the starting material. Arresting the reaction followed by workup resulted in isolation of **7aaa** in 28% yield together with another solid product (49%) that was spectroscopically established to be the spirooxindole **6a**. Additionally, arresting the reaction between **1f**, **3a**, and **5a** after 4 h gave spirooxindole **6b** in 35% yield together with **7faa** in 24% yield. However, all efforts to obtain spirooxindole **6** exclusively from the reactions between isatin **1**, **3a**, and **5a** were unsuccessful. Isolation of **6** suggested that the reaction proceeds via the intermediacy of spirooxindole, which then undergoes C2--C3 bond cleavage followed by the attack of the second THIQ unit. To ascertain it unambiguously, we heated the spirooxindole **6a** with **5a** in toluene, which produced **7aaa** in 94% yield ([Scheme [7](#sch7){ref-type="scheme"}](#sch7){ref-type="scheme"}). Further treating spirooxindole **6a** with **9a** furnished **10aaaa** in 81% yield. Although we could not isolate the isocyanate, it was discovered that the reaction of spirooxindole **6a** with Cs~2~CO~3~ in dimethylformamide (DMF) gave the aniline **11** in 93% yield as reported earlier^[@ref9]^ ([Scheme [7](#sch7){ref-type="scheme"}](#sch7){ref-type="scheme"}).

![Results of Control Experiments](ao9b03546_0002){#sch6}

![Reactions of Spirooxindole **6** with THIQ, Cs~2~CO~3~, and Different Amines](ao9b03546_0003){#sch7}

These control reactions inferred that the reaction of spirooxindole **6a** with any primary or secondary amine should offer the corresponding urea derivative **10**. Accordingly, **6a** was treated with different amines **9a**, **9l**, **9p**, or **9q**, and gratifyingly in each case, the corresponding urea **10aaaa**, **10aaal**, **10aaap**, or **10aaaq** was isolated in excellent yields ([Scheme [7](#sch7){ref-type="scheme"}](#sch7){ref-type="scheme"}). Based on these studies, the plausible mechanism for the formation of urea derivatives is delineated in [Scheme [8](#sch8){ref-type="scheme"}](#sch8){ref-type="scheme"}. The initial imine formation between the isatin **1** and THIQ **5** leads to azomethine ylide **A**, which, via \[3+2\] cycloaddition of the alkyne **3**, produces spirooxindole **6**. However, under basic conditions, **6** undergoes C2--C3 bond cleavage to offer the isocyanate **B**, which suffers the nucleophilic attack by the amine to afford the title compound **7**. The extended conjugation of the pyrrole and the benzene ring as observed in **7** is anticipated to be one of the influencing factors for the skeletal rearrangement in spirooxindole **6**. To gain support for this reasoning, we performed the reactions of Cs~2~CO~3~ with spirooxindoles **4** and **12**,^[@ref6]^ which were unsuccessful ([Scheme [9](#sch9){ref-type="scheme"}](#sch9){ref-type="scheme"}).

![Plausible Mechanism for the Formation of **7**](ao9b03546_0004){#sch8}

![Reaction of **4** and **12** with Cs~2~CO~3~](ao9b03546_0006){#sch9}

Finally, to explore the synthetic transformations of **7aaa**, we performed a few robust synthetic transformations. Oxidative thiocyanation of **7aaa** with ammonium thiocyanate (NH~4~SCN) in the presence of ceric ammonium nitrate (CAN) in methanol furnished **13** in 89% yield ([Scheme [10](#sch10){ref-type="scheme"}](#sch10){ref-type="scheme"}).^[@ref11]^ The halogenation reaction of **7aaa** using *N*-bromosuccinimide (NBS)^[@cit5i]^ resulted in the formation of **14** in 87% yield. Basic hydrolysis of the urea moiety of **7aaa** afforded aniline **11** in 58% yield. Next, we treated **7aaa** with Lawesson's reagent in toluene as the medium under microwave heating for 2 h, which gave aniline **11** in 94% yield, instead of the expected thiourea derivative **15**. Nonetheless, treating **11** with 3-chlorophenyl isothiocyanate in methanol afforded the thiourea derivative **15a** in 55% yield. To investigate whether the spirooxindole **6** would undergo the POCl~3~-mediated dehydrative transformation as reported by us earlier,^[@ref6]^ we heated **6a** and **6b** with POCl~3~ at 90 °C for 24 and 48 h, respectively, to obtain fused-pyrido\[2,3-*b*\]indoles **16a** and **16b** in 74--84% yield.

![Synthetic Transformations of Dihydropyrrolo\[2,1-*a*\]isoquinoline **7aaa** and Spirooxindole **6**\
Yield calculated based on % conversion of the starting material.](ao9b03546_0005){#sch10}

Conclusions {#sec3}
===========

In conclusion, we have developed a multicomponent route for the synthesis of 5,6-dihydropyrrolo\[2,1-*a*\]isoquinolines incorporating the urea moiety using isatins, THIQ, and terminal alkynes as the starting substrates. A variety of isatins and terminal alkynes are compatible in the reaction to offer the corresponding *N*-(substituted-2-(2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamides in moderate to excellent yields. The four-component reactions between isatin, THIQ, primary amines, and terminal alkynes were found to be successful to afford 1-substituted-3-(2-(2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)ureas (from primary amines) in moderate yields together with carboxamides (from THIQ). However, we demonstrate that this limitation of the 4CR can be circumvented by performing the reaction of the spirooxindole intermediate with primary or secondary amines to prepare the 1-substituted-3-(2-(2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)ureas in excellent yields. This protocol allows generation of molecular complexity from the readily available starting materials in a single step under transition metal-free conditions. We have also demonstrated the utility of the obtained products for further diversification for medicinal chemistry programs. Studies concerning newer applications of the present protocol and biological assessment of the synthesized 5,6-dihydropyrrolo\[2,1-*a*\]isoquinolines are underway in the laboratory.

Experimental Section {#sec4}
====================

General Information {#sec4.1}
-------------------

All reactions were monitored by thin layer chromatography (TLC) on precoated silica gel plates. After elution, the TLC plate was visualized under UV illumination at 254 nm. The melting points were recorded on a hot stage apparatus and are uncorrected. IR spectra were recorded on a FTIR spectrophotometer. The NMR spectra were recorded on Bruker 300, 400, and 500 MHz spectrometers. Chemical shifts are reported in ppm, and peak multiplicities of NMR signals are designated as s (singlet), d (doublet), dd (doublet of doublet), dt (doublet of triplet), t (triplet), q (quartet), and m (multiplet). The ESI-MS were recorded on an Ion Trap Mass spectrometer. The HRMS spectra were recorded as ESI-HRMS on a Q-TOF LC--MS/MS mass spectrometer. Commercial grade reagents and solvents were used as received without further purification. The microwave reactions were carried out in a Monowave reactor equipped with magnetron to deliver continuous microwave power.

Experimental Procedure for the Synthesis of 2′-Phenyl-10′,10*a*′-dihydro-5′*H*-spiro\[indoline-3,3′-pyrrolo\[1,2-*b*\]isoquinolin\]-2-one (**4**) {#sec4.2}
-------------------------------------------------------------------------------------------------------------------------------------------------

A 30 mL microwave vial was charged with isatin **1a** (4.078 mmol, 0.6 g), 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid **2a** (4.078 mmol, 0.72 g), and phenyl acetylene **3a** (4.078 mmol, 0.446 g) and molecular sieves (4 Å) (0.55 g) in 5 mL of acetonitrile. The vial was irradiated at 150 °C for 1 h, after which the reaction mixture was passed through a bed of Celite using EtOAc. The filtrate was collected and concentrated to obtain a crude residue, which was purified by column chromatography over silica gel using hexanes/EtOAc (75:25, v/v) as the eluent to obtain 0.08 g (5%) of **4** as an off-white solid. mp 219--224 °C; *R~f~* = 0.68 (hexanes/EtOAc, 6:4 v/v); IR (KBr) ν~max~: 1736 (C=O), 3451 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ = 2.92--3.04 (m, 1H), 3.06--3.16 (m, 1H), 3.54 (d, *J* = 13.9 Hz, 1H), 4.03 (d, *J* = 13.8 Hz, 1H), 4.38--4.48 (m, 1H), 6.66 (s, 1H), 6.87 (d, *J* = 7.6 Hz, 1H), 6.91--6.99 (m, 2H), 7.08--7.22 (m, 10H), 7.92 (s, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 35.9, 46.7, 62.6, 78.3, 109.9, 123.5, 125.9, 126.1, 126.4, 127.0, 127.9, 128.5, 128.5, 129.7, 129.8, 132.6, 133.7, 134.7, 135.3, 141.6, 142.9, 177.8. MS (ESI+): *m*/*z* = 365.3. ESI-HR-MS calculated for C~26~H~21~NO \[MH\]^+^: 365.1648, found: 365.1649.

General Experimental Procedure for the Synthesis of *N*-Substituted-2-(2-Phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamides **7** As Exemplified for **7aaa** {#sec4.3}
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

To a stirred solution of isatin **1a** (2.04 mmol, 0.3 g) in toluene (15 mL) were added THIQ **5a** (4.08 mmol, 0.543 g), phenyl acetylene **3a** (2.04 mmol, 224 μL), and benzoic acid (20 mol %, 0.049 g), and the mixture was heated at 90 °C for 16 h. After completion, the solvent was evaporated to obtain a crude product, which was purified by column chromatography over silica gel using hexanes/EtOAc (70:30, v/v) as eluent to furnish 0.869 g (86%) of **7aaa** as a white solid.

### *N*-(2-(2-Phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**7aaa**) {#sec4.3.1}

mp 80--84 °C; *R~f~* = 0.68 (hexanes/EtOAc, 6:4 v/v); IR (KBr) ν~max~: 1670 (C=O), 3405 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.65 (t, *J* = 5.7 Hz, 2H), 2.87--3.03 (m, 2H), 3.23--3.34 (m, 2H), 3.67--3.73 (m, 1H), 3.85--3.92 (m, 1H), 4.11--4.22 (m, 2H), 6.73 (s, 1H), 6.92--6.95 (m, 2H), 7.02--7.24 (m, 9H), 7.27--7.38 (m, 4H), 7.40--7.45 (m, 1H), 7.65 (d, *J* = 7.6 Hz, 1H), 8.15 (d, *J* = 8.3 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 28.8, 29.4, 41.2, 41.8, 45.4, 103.0, 120.6, 121.3, 122.6, 122.6, 123.8, 125.2, 126.2, 126.3, 126.4, 126.7, 127.4, 128.2, 128.3, 128.8, 129.0, 129.8, 131.1, 131.5, 131.7, 133.1, 134.9, 135.1, 138.3, 154.5. MS (ESI+): *m*/*z* = 496.1. ESI-HR-MS calculated for C~34~H~29~N~3~O \[MH\]^+^: 496.2383, found: 496.2378.

### *N*-(4-Methyl-2-(2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**7baa**) {#sec4.3.2}

Yield: 89% (0.844 g from 0.3 g of **1b**); a white solid, mp 135--138 °C; *R~f~* = 0.46 (hexanes/EtOAc, 7:3 v/v); IR (KBr) ν~max~: 1723 (C=O), 3434 (N--H) cm^--1^.^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.37 (s, 3H), 2.64 (t, *J* = 5.9 Hz, 2H), 2.86--3.03 (m, 2H), 3.25--3.29 (m, 2H), 3.67--3.74 (m, 1H), 3.85--3.92 (m, 1H), 4.10--4.20 (m, 2H), 6.62 (s, 1H), 6.92--6.94 (m, 2H), 7.03--7.35 (m, 13H), 7.63 (d, *J* = 7.6 Hz, 1H), 8.00 (d, *J* = 8.4 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 20.8, 28.7, 29.3, 41.1, 41.7, 45.2, 102.8, 120.7, 121.3, 122.5, 123.5, 125.3, 126.0, 126.2, 126.6, 127.2, 128.0, 128.2, 128.7, 129.0, 130.3, 131.0, 131.4, 131.5, 131.9, 133.1, 134.9, 135.1, 135.6, 154.5. MS (ESI+): *m*/*z* = 510.2. ESI-HR-MS calculated for C~35~H~31~N~3~O \[MH\]^+^: 510.2540, found: 510.2543.

### *N*-(4-Methoxy-2-(2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**7caa**) {#sec4.3.3}

Yield: 92% (0.818 g from 0.3 g of **1c**); a white solid, mp 196--199 °C; *R~f~* = 0.51 (hexanes/EtOAc, 6:4 v/v); IR (KBr) ν~max~: 1660 (C=O), 3414 (N--H) cm^--1^.^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.58 (t, *J* = 5.8 Hz, 2H), 2.79--2.95 (m, 2H), 3.16--3.26 (m, 2H), 3.64--3.70 (m, 1H), 3.76 (s, 3H), 3.81--3.87 (m, 1H), 4.03--4.12 (m, 2H), 6.39 (s, 1H), 6.83--6.88 (m, 3H), 6.91--6.96 (m, 2H), 7.02--7.10 (m, 5H), 7.14--7.23 (m, 4H), 7.27--7.28 (m, 1H), 7.56 (d, *J* = 7.6 Hz, 1H), 7.92 (d, *J* = 9.0 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 28.7, 29.2, 41.0, 41.7, 45.2, 55.6, 102.8, 114.7, 116.6, 122.5, 122.8, 123.1, 123.6, 125.1, 126.1, 126.2, 126.2, 126.3, 126.6, 127.2, 128.1, 128.2, 128.7, 128.9, 131.0, 131.4, 131.5, 133.1, 134.9, 135.0, 154.7, 155.0. MS (ESI+): *m*/*z* = 526.1. ESI-HR-MS calculated for C~35~H~31~N~3~O~2~ \[MH\]^+^: 526.2489, found: 526.2485.

### *N*-(4-Fluoro-2-(2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**7daa**) {#sec4.3.4}

Yield: 87% (0.81 g from 0.3 g of **1d**); a brown solid, mp 215--218 °C; *R~f~* = 0.60 (hexanes/EtOAc, 6:4 v/v); IR (KBr) ν~max~: 1674 (C=O), 3352 (N--H) cm^--1^.^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.66 (t, *J* = 5.8 Hz, 2H), 2.88--3.05 (m, 2H), 3.22--3.33 (m, 2H), 3.69--3.75 (m, 1H), 3.87--3.94 (m, 1H), 4.11--4.20 (m, 2H), 6.59 (s, 1H), 6.92--6.95 (m, 2H), 7.02--7.33 (m, 13H), 7.64 (d, *J* = 7.7 Hz, 1H), 8.08 (dd, *J*~1~ = 9.1 Hz, *J*~2~ = 5.4 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 28.6, 29.1, 41.1, 41.7, 45.2, 103.0, 116.2 (d, *J* = 22 Hz), 117.6 (d, *J* = 22 Hz), 122.6, 122.7, 123.0, 123.1, 123.8, 124.0, 126.1, 126.3, 126.5, 126.6, 127.2, 128.0, 128.2, 128.7, 128.7, 130.0, 130.8, 131.8, 132.9, 134.3, 134.7, 134.7, 154.4, 157.9 (d, *J* = 243 Hz). MS (ESI+): *m*/*z* = 514.1. ESI-HR-MS calculated for C~34~H~28~FN~3~O \[MH\]^+^: 514.2289, found: 514.2297.

### *N*-(4-Chloro-2-(2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**7eaa**) {#sec4.3.5}

Yield: 90% (0.787 g from 0.3 g of **1e**); a white solid, mp 141--142 °C; *R~f~* = 0.56 (hexanes/EtOAc, 7:3 v/v); IR (KBr) ν~max~: 1664 (C=O), 3412 (N--H) cm^--1^.^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.65 (t, *J* = 5.5 Hz, 2H), 2.89--3.06 (m, 2H), 3.24--3.28 (m, 2H), 3.67--3.73 (m, 1H), 3.88--3.94 (m, 1H), 4.09--4.20 (m, 2H), 6.70 (s, 1H), 6.93--6.95 (m, 2H), 7.03--7.40 (m, 13H), 7.64 (d, *J* = 7.7 Hz, 1H), 8.12 (d, *J* = 8.9 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 28.6, 29.2, 41.1, 41.8, 45.2, 103.0, 121.8, 122.6, 122.8, 123.4, 124.2, 126.2, 126.3, 126.3, 126.4, 126.5, 126.7, 127.2, 127.3, 128.1, 128.2, 128.7, 128.8, 129.6, 130.8, 130.9, 132.0, 132.9, 134.6, 134.8, 136.9, 154.1. MS (ESI+): *m*/*z* = 530.1. ESI-HR-MS calculated for C~34~H~28~ClN~3~O \[MH\]^+^: 530.1994, found: 530.1993.

### *N*-(4-Bromo-2-(2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**7faa**) {#sec4.3.6}

Yield: 89% (0.677 g from 0.3 g of **1f**); a white solid, mp 201--202 °C; *R~f~* = 0.7 (hexanes/EtOAc, 8:2 v/v); IR (CHCl~3~) ν~max~: 1661 (C=O), 3405 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.65 (t, *J* = 5.5 Hz, 2H), 2.90--2.98 (m, 1H), 3.01--3.08 (m, 1H), 3.21--3.30 (m, 2H), 3.68--3.74 (m, 1H), 3.89--3.95 (m, 1H), 4.09--4.20 (m, 2H), 6.71 (s, 1H), 6.93--6.95 (m, 2H), 7.03--7.05 (m, 1H), 7.10--7.24 (m, 7H), 7.30--7.34 (m, 3H), 7.49--7.54 (m, 2H), 7.64 (d, *J* = 7.6 Hz, 1H), 8.07 (d, *J* = 8.9 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 28.8, 29.4, 41.3, 41.9, 45.3, 103.2, 114.8, 122.2, 122.8, 123.3, 123.5, 124.3, 126.3, 126.4, 126.5, 126.6, 126.7. MS (ESI+): *m*/*z* = 574.2. ESI-HR-MS calculated for C~34~H~28~BrN~3~O \[MH\]^+^: 574.1489, found: 574.1486.

### *N*-(4-Nitro-2-(2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**7gaa**) {#sec4.3.7}

Yield: 82% (0.692 g from 0.3 g of **1 g**); a yellow solid, mp 218--220 °C; *R~f~* = 0.50 (hexanes/EtOAc, 7:3 v/v); IR (KBr) ν~max~: 1676 (C=O), 3393 (N--H) cm^--1^.^1^H NMR (400 MHz, DMSO-*d*~6~): δ (ppm) = 2.57--2.60 (m, 2H), 2.93--3.00 (m, 1H), 3.05--3.12 (m, 1H), 3.21--3.26 (m, 2H), 3.71--3.77 (m, 1H), 3.91--3.97 (m, 1H), 4.09--4.25 (m, 2H), 6.96--6.98 (m, 1H), 7.07--7.19 (m, 10H), 7.25--7.32 (m, 2H), 7.72 (d, *J* = 7.5 Hz, 1H), 7.80 (s, 1H), 8.08 (d, *J* = 9.1 Hz, 1H), 8.26--8.30 (m, 2H); ^13^C NMR (100 MHz, DMSO-*d*~6~): δ (ppm) = 28.3, 28.7, 41.5, 41.9, 45.6, 103.9, 120.7, 122.9, 123.1, 123.6, 123.7, 125.3, 126.3, 126.4, 126.5, 126.7, 126.9, 127.5, 127.8, 128.5, 128.7, 128.9, 129.0, 131.6, 131.8, 133.4, 135.0, 135.4, 142.1, 146.0, 153.6. MS (ESI+): *m*/*z* = 541.0. ESI-HR-MS calculated for C~34~H~28~N~4~O~3~ \[MH\]^+^: 541.2234, found: 541.2230.

### *N*-(5-Chloro-2-(2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**7haa**) {#sec4.3.8}

Yield: 85% (0.743 g from 0.3 g of **1h**); a brown solid, mp 83--85 °C; *R~f~* = 0.52 (hexanes/EtOAc, 8:2 v/v); IR (KBr) ν~max~: 1673 (C=O), 3398 (N--H) cm^--1^.^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.65 (t, *J* = 5.6 Hz, 2H), 2.88--3.04 (m, 2H), 3.21--3.30 (m, 2H), 3.65--3.72 (m, 1H), 3.83--3.90 (m, 1H), 4.09--4.21 (m, 2H), 6.76 (s, 1H), 6.92--6.94 (m, 2H), 7.03--7.34 (m, 13H), 7.64 (d, *J* = 7.6 Hz, 1H), 8.28 (d, *J* = 2.0 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 28.8, 29.3, 41.3, 41.8, 45.3, 103.1, 119.4, 120.5, 122.6, 122.7, 123.8, 124.2, 126.3, 126.5, 126.6, 126.8, 127.4, 128.2, 128.3, 128.9, 131.0, 132.1, 132.3, 132.9, 134.8, 134.8, 135.6, 139.4, 154.1. MS (ESI+): *m*/*z* = 530.01. ESI-HR-MS calculated for C~34~H~28~ClN~3~O \[MH\]^+^: 530.1994, found: 530.2001.

### *N*-(2-Fluoro-6-(2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**7iaa**) {#sec4.3.9}

Yield: 81% (0.755 g from 0.3 g of **1i**); a white solid, mp 149--151 °C; *R~f~* = 0.64 (hexanes/EtOAc, 7:3 v/v); IR (KBr) ν~max~: 1664 (C=O), 3406 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.67 (t, *J* = 6.1 Hz, 2H), 2.91--2.99 (m, 2H), 3.31--3.35 (m, 2H), 3.83--3.95 (m, 2H), 4.14--4.29 (m, 2H), 5.75 (s, 1H), 6.78 (s, 1H), 6.97--7.03 (m, 2H), 7.10--7.25 (m, 13H), 7.57 (d, *J* = 7.5 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 28.7, 29.2, 41.3, 41.9, 45.6, 103.1, 116.5 (d, *J* = 21 Hz), 122.5, 123.9, 125.1, 125.9, 126.0, 126.1, 126.2, 126.2, 126.6, 126.7, 127.1, 127.2, 128.0, 128.4, 128.8, 129.0, 129.4, 131.1, 131.4, 133.0, 134.8, 135.5, 154.3, 157.8 (d, *J* = 250 Hz). MS (ESI+): *m*/*z* = 514.5. ESI-HR-MS calculated for C~34~H~28~FN~3~O \[MH\]^+^: 514.2289, found: 514.2283.

### *N*-(2-(2-(*p*-Tolyl)-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**7aab**) {#sec4.3.10}

Yield: 81% (0.84 g from 0.3 g of **1a**); a brown solid, mp 110--113 °C; *R~f~* = 0.43 (hexanes/EtOAc, 8:2 v/v); IR (KBr) ν~max~: 1668 (C=O), 3388 (N--H) cm^--1^.^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.28 (s, 3H), 2.66 (t, *J* = 5.6 Hz, 2H), 2.90--3.03 (m, 2H), 3.23--3.35 (m, 2H), 3.66--3.72 (m, 1H), 3.84--3.91 (m, 1H), 4.11--4.21 (m, 2H), 6.75 (s, 1H), 6.92--6.94 (m, 2H), 7.02--7.35 (m, 12H), 7.40--7.44 (m, 1H), 7.63 (d, *J* = 7.7 Hz, 1H), 8.14 (d, *J* = 8.1 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 21.0, 28.7, 29.3, 41.1, 41.6, 45.3, 102.8, 120.5, 121.4, 122.4, 122.5, 123.7, 124.7, 126.1, 126.2, 126.2, 126.6, 127.2, 128.0, 128.2, 129.0, 129.4, 129.6, 130.9, 131.3, 131.5, 132.0, 133.1, 134.8, 135.7, 138.1, 154.4. MS (ESI+): *m*/*z* = 510.1. ESI-HR-MS calculated for C~35~H~31~N~3~O \[MH\]^+^: 510.2540, found: 510.2542.

### *N*-(2-(2-(4-(*tert*-Butyl)phenyl)-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**7aac**) {#sec4.3.11}

Yield: 79% (0.89 g from 0.3 g of **1a**); a white solid, mp 95--98 °C; *R~f~* = 0.51 (hexanes/EtOAc, 7:3 v/v); IR (KBr) ν~max~: 1711 (C=O), 3409 (N--H) cm^--1^.^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.26 (s, 9H), 2.58--2.67 (m, 2H), 2.84--3.02 (m, 2H), 3.20--3.29 (m, 2H), 3.65--3.71 (m, 1H), 3.83--3.90 (m, 1H), 4.10--4.24 (m, 2H), 6.77 (s, 1H), 6.92--6.92 (m, 2H), 7.02--7.18 (m, 8H), 7.27--7.30 (m, 3H), 7.34 (dd, *J*~1~ = 7.6 Hz, *J*~2~ = 1.3 Hz, 1H), 7.41--7.45 (m, 1H), 7.64 (d, *J* = 7.7 Hz, 1H). 8.18 (d, *J* = 8.1 Hz, 1H); ^13^C NMR (100 MHz, DMSO-*d*~6~): δ (ppm) = 28.2, 28.8, 31.5, 34.4, 41.4, 41.7, 45.5, 103.5, 122.2, 122.7, 122.8, 123.4, 123.8, 125.5, 125.7, 126.0, 126.4, 126.8, 127.4, 128.5, 128.7, 129.1, 129.4, 130.8, 131.4, 132.1, 132.7, 133.7, 135.0, 138.9, 148.2, 154.5. MS (ESI+): *m*/*z* = 552.2. ESI-HR-MS calculated for C~38~H~37~N~3~O \[MH\]^+^: 552.3009, found: 552.3003.

### *N*-(2-(2-(4-Bromophenyl)-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**7aad**) {#sec4.3.12}

Yield: 85% (0.99 g from 0.3 g of **1a**); a yellow solid, mp 174--177 °C; *R~f~* = 0.50 (hexanes/EtOAc, 7:3 v/v); IR (KBr) ν~max~: 1658 (C=O), 3382 (N--H) cm^--1^.^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.67 (t, *J* = 5.8 Hz, 2H), 2.86--3.03 (m, 2H), 3.25--3.36 (m, 2H), 3.66--3.72 (m, 1H), 3.83--3.90 (m, 1H), 4.14--4.23 (m, 2H), 6.65 (s, 1H), 6.90--6.93 (m, 2H), 7.03--7.18 (m, 8H), 7.27--7.32 (m, 4H), 7.41--7.45 (m, 1H), 7.63 (d, *J* = 7.7 Hz, 1H), 8.16 (d, *J* = 8.2 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 28.7, 29.3, 41.3, 41.8, 45.5, 102.7, 119.9, 120.7, 121.0, 122.6, 122.7, 125.3, 126.3, 126.5, 126.6, 126.8, 127.4, 127.8, 128.2, 128.4, 128.8, 130.0, 131.1, 131.4, 131.9, 131.9, 133.1, 134.1, 134.9, 138.4, 154.4. MS (ESI+): *m*/*z* = 574.1. ESI-HR-MS calculated for C~34~H~28~BrN~3~O \[MH\]^+^: 574.1489, found: 574.1485.

### *N*-(2-(2-(4-Fluorophenyl)-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**7aae**) {#sec4.3.13}

Yield: 78% (0.82 g from 0.3 g of **1a**); a brown solid, mp 92--95 °C; *R~f~* = 0.45 (hexanes/EtOAc, 7:3 v/v); IR (KBr) ν~max~: 1662 (C=O), 3385 (N--H) cm^--1^.^1^H NMR (400 MHz, DMSO-*d*~6~): δ (ppm) = 2.63 (t, *J* = 5.6 Hz, 2H), 2.92--3.06 (m, 2H), 3.28--3.33 (m, 2H), 3.74--3.87 (m, 2H), 4.26 (s, 2H), 6.98--7.03 (m, 4H), 7.10--7.11 (m, 2H), 7.15--7.24 (m, 6H), 7.32 (t, *J* = 7.4 Hz, 1H), 7.38--7.40 (m, 1H), 7.45 (t, *J* = 7.6 Hz, 1H), 7.48 (s, 1H), 7.71 (d, *J* = 7.7 Hz, 1H), 7.75 (d, *J* = 8.1 Hz, 1H); ^13^C NMR (100 MHz, DMSO-*d*~6~): δ (ppm) = 28.3, 28.8, 41.4, 41.8, 45.7, 103.6, 115.0 (d, *J* = 21.2 Hz), 121.8, 122.7, 123.5, 123.8, 124.7, 126.3, 126.3, 126.4, 126.6, 126.7, 127.4, 128.2 (d, *J* = 7.7 Hz), 128.4, 128.7, 129.3, 129.4, 130.6, 131.5, 132.2, 132.5, 133.9, 135.1, 139.3, 154.8, 160.7 (d, *J* = 241.5 Hz). MS (ESI+): *m*/*z* = 514.1. ESI-HR-MS calculated for C~34~H~28~FN~3~O \[MH\]^+^: 514.2289, found: 514.2286.

### *N*-(2-(2-(2-Chlorophenyl)-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**7aaf**) {#sec4.3.14}

Yield: 84% (0.906 g from 0.3 g of **1a**); a white solid, mp 117--120 °C; *R~f~* = 0.42 (hexanes/EtOAc, 7:3 v/v); IR (KBr) ν~max~: 1670 (C=O), 3451 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.76 (t, *J* = 5.8 Hz, 2H), 2.82--2.89 (m, 1H), 2.94--3.01 (m, 1H), 3.47 (t, *J* = 5.5 Hz, 2H), 3.69--3.76 (m, 1H), 3.79--3.86 (m, 1H), 4.31--4.45 (m, 2H), 6.59 (s, 1H), 6.96--6.99 (m, 1H), 7.03--7.10 (m, 7H), 7.12--7.15 (m, 3H), 7.25--7.30 (m, 2H), 7.33--7.37 (m, 2H), 7.63 (d, *J* = 7.7 Hz, 1H), 8.02 (d, *J* = 8.2 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 28.8, 29.4, 41.6, 42.0, 45.7, 106.2, 121.2, 121.3, 122.0, 122.6, 122.8, 126.4, 126.8, 126.9, 127.4, 128.0, 128.2, 128.4, 129.1, 129.7, 130.0, 130.7, 131.0, 131.9, 132.9, 133.3, 134.1, 134.9, 138.5, 154.7. MS (ESI+): *m*/*z* = 530.5. ESI-HR-MS calculated for C~34~H~28~ClN~3~O \[MH\]^+^: 530.1994, found: 530.1990.

### *N*-(2-(2-(3,4-Dichlorophenyl)-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**7aag**) {#sec4.3.15}

Yield: 83% (0.95 g from 0.3 g of **1a**); a brown solid, mp 96--99 °C; *R~f~* = 0.44 (hexanes/EtOAc, 7:3 v/v); IR (KBr) ν~max~: 1642 (C=O), 3452 (N--H) cm^--1^.^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.69 (t, *J* = 5.8 Hz, 2H), 2.87--2.93 (m, 1H), 2.97--3.03 (m, 1H), 3.31--3.36 (m, 2H), 3.68--3.73 (m, 1H), 3.84--3.89 (m, 1H), 4.19--4.26 (m, 2H), 6.61 (s, 1H), 6.90--6.94 (m, 2H), 6.99--7.02 (m, 1H), 7.04--7.06 (m, 1H), 7.11--7.22 (m, 6H), 7.29--7.32 (m, 2H), 7.44--7.48 (m, 2H), 7.65 (d, *J* = 7.7 Hz, 1H), 8.18 (d, *J* = 8.3 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 28.7, 29.3, 41.5, 41.9, 45.6, 102.7, 120.6, 120.8, 121.5, 122.8, 122.9, 125.4, 125.7, 126.3, 126.6, 126.8, 126.9, 127.5, 128.0, 128.3, 128.4, 128.7, 129.7, 130.3, 130.7, 131.1, 131.3, 132.1, 132.7, 132.9, 134.8, 135.5, 138.4, 154.4. MS (ESI+): *m*/*z* = 564.2. ESI-HR-MS calculated for C~34~H~27~Cl~2~N~3~O \[MH\]^+^: 564.1604, found: 564.1609.

### *N*-(2-(2-(Pyridin-3-yl)-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**7aah**) {#sec4.3.16}

Yield: 78% (0.79 g from 0.3 g of **1a**); a yellow solid, mp 75--78 °C; *R~f~* = 0.67 (hexanes/EtOAc, 3:7 v/v); IR (KBr) ν~max~: 1655 (C=O), 3412 (N--H) cm^--1^.^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.68 (t, *J* = 5.7 Hz, 2H), 2.91--3.02 (m, 2H), 3.30--3.33 (m, 2H), 3.68--3.75 (m, 1H), 3.83--3.89 (m, 1H), 4.16--4.25 (m, 2H), 6.64 (s, 1H), 6.93--6.94 (m, 1H), 6.97 (s, 1H), 7.02--7.04 (m, 1H), 7.06--7.10 (m, 3H), 7.13--7.18 (m, 3H), 7.29--7.33 (m, 2H), 7.44--7.47 (m, 2H), 7.66 (d, *J* = 7.6 Hz, 1H), 8.18 (d, *J* = 8.2 Hz, 1H), 8.36 (dd, *J*~1~ = 4.8 Hz, *J*~2~ = 1.1 Hz, 1H), 8.72 (d, *J* = 1.5 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 28.7, 29.2, 41.4, 41.8, 45.5, 102.6, 120.3, 120.6, 120.6, 122.8, 122.9, 123.7, 125.9, 126.3, 126.5, 126.8, 126.9, 127.5, 128.3, 128.4, 130.3, 131.1, 131.2, 131.4, 132.2, 133.0, 133.1, 134.8, 138.5, 147.1, 147.7, 154.4. MS (ESI+): *m*/*z* = 497.4. ESI-HR-MS calculated for C~33~H~28~N~4~O \[MH\]^+^: 497.2336, found: 497.2341.

### *N*-(2-(2-(Thiophen-3-yl)-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**7aai**) {#sec4.3.17}

Yield: 80% (0.82 g from 0.3 g of **1a**); a brown solid, mp 101--102 °C; *R~f~* = 0.44 (hexanes/EtOAc, 7:3 v/v); IR (KBr) ν~max~: 1710 (C=O), 3413 (N--H) cm^--1^.^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.67 (t, *J* = 5.4 Hz, 2H), 2.85--3.04 (m, 2H), 3.26--3.37 (m, 2H) 3.66--3.74 (m, 1H), 3.82--3.91 (m, 1H), 4.13--4.24 (m, 2H), 6.80 (s, 1H), 6.88--6.95 (m, 2H), 6.96--7.00 (m, 1H), 7.05--7.23 (m, 8H), 7.27--7.34 (m, 2H), 7.42--7.48 (m, 1H), 7.63 (d, *J* = 7.7 Hz, 1H), 8.21 (d, *J* = 8.2 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 28.8, 29.4, 41.2, 41.8, 45.4, 102.7, 118.3, 119.5, 120.4, 121.1, 122.5, 122.6, 124.8, 125.7, 126.3, 126.4, 126.5, 126.7, 127.4, 128.2, 128.4, 129.0, 130.0, 131.1, 131.3, 131.5, 133.1, 134.9, 135.8, 138.6, 154.5. MS (ESI+): *m*/*z* = 502.4. ESI-HR-MS calculated for C~32~H~27~N~3~OS \[MH\]^+^: 502.1948, found: 502.1947.

### *N*-(2-(2-(Cyclohex-1-en-1-yl)-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**7aaj**) {#sec4.3.18}

Yield: 74% (0.75 g from 0.3 g of **1a**); a brown solid, mp 79--82 °C; *R~f~* = 0.56 (hexanes/EtOAc, 8:2 v/v); IR (KBr) ν~max~: 1706 (C=O), 3394 (N--H) cm^--1^.^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.57--1.63 (m, 4H), 1.91--2.11 (m, 4H), 2.77--2.81 (m, 2H), 2.82--2.98 (m, 2H), 3.52 (t, *J* = 5.9 Hz, 2H), 3.56--3.66 (m, 1H), 3.72--3.86 (m, 1H), 4.31--4.54 (m, 2H), 5.81 (s, 1H), 6.69 (s, 1H), 6.91 (s, 1H), 6.97--7.01 (m, 1H), 7.05--7.16 (m, 7H), 7.22--7.25 (m, 1H), 7.36--7.42 (m, 1H), 7.58 (d, *J* = 7.6 Hz, 1H), 8.20 (d, *J* = 8.05 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 22.3, 23.2, 25.8, 28.2, 28.9, 29.4, 41.4, 41.6, 45.6, 102.2, 120.1, 122.2, 122.5, 123.0, 123.9, 126.1, 126.3, 126.5, 126.8, 127.3, 128.1, 128.4, 129.2, 129.5, 130.7, 131.0, 131.1, 131.5, 133.2, 134.9, 138.7, 154.7. MS (ESI+): *m*/*z* = 500.4. ESI-HR-MS calculated for C~34~H~33~N~3~O \[MH\]^+^: 500.2696, found: 500.2690.

### *N*-(2-(2-Cyclopropyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**7aak**) {#sec4.3.19}

Yield: 59% (0.55 g from 0.3 g of **1a**); a brown solid, mp 86--88 °C; *R~f~* = 0.66 (hexanes/EtOAc, 7:3 v/v); IR (KBr) ν~max~: 1663 (C=O), 3395 (N--H) cm^--1^.^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 0.72--0.74 (m, 2H), 1.16--1.19 (m, 2H), 2.70--2.74 (m, 2H), 2.77--2.81 (m, 1H), 2.84--2.90 (m, 1H), 3.44--3.51 (m, 2H), 3.53--3.60 (m, 1H), 3.69--3.75 (m, 1H), 4.04 (q, *J* = 7.12 Hz, 1H) 4.29--4.33 (m, 1H), 4.43--4.47 (m, 1H), 6.14 (s, 1H), 6.88--6.93 (m, 2H), 6.98--7.04 (m, 6H), 7.14--7.16 (m, 1H), 7.19--7.21 (m, 1H), 7.30--7.35 (m, 1H), 7.44 (d, *J* = 7.7 Hz, 1H), 8.20 (d, *J* = 8.3 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 7.6, 8.9, 8.9, 28.9, 29.5, 41.5, 41.7, 45.7, 99.2, 119.9, 120.8, 122.2, 122.4, 125.6, 126.1, 126.4, 126.5, 126.6, 126.9, 127.3, 128.2, 128.5, 129.3, 129.6, 130.9, 131.2, 131.5, 133.2, 135.0, 139.0, 154.8. MS (ESI+): *m*/*z* = 460.3. ESI-HR-MS calculated for C~31~H~29~N~3~O \[MH\]^+^: 460.2383, found: 460.2390.

### *N*-(2-(2-(Trimethylsilyl)-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**7aal**) {#sec4.3.20}

Yield: 56% (0.561 g from 0.3 g of **1a**); a yellow oil; *R~f~* = 0.47 (hexanes/EtOAc, 7:3 v/v); IR (CHCl~3~) ν~max~: 1678 (C=O), 3421 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 0.09 (s, 9H), 2.70--2.83 (m, 3H), 2.90--2.98 (m, 1H), 3.40--3.54 (m, 2H), 3.59--3.74 (m, 2H), 4.18--4.47 (m, 2H), 6.54 (s, 1H), 6.82 (s, 1H), 6.88 (d, *J* = 7.4 Hz, 1H), 7.04 (t, *J* = 7.6 Hz, 2H), 7.08--7.18 (m, 4H), 7.29--7.35 (m, 2H), 7.43--7.52 (m, 1H), 7.68 (d, *J* = 7.7 Hz, 1H), 8.30 (d, *J* = 7.9 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 0.03, 28.5, 29.4, 41.5, 41.5, 45.7, 109.6, 118.5, 119.4, 122.1, 122.6, 122.9, 126.1, 126.2, 126.4, 126.8, 127.3, 128.4, 129.3, 130.1, 130.6, 131.4, 131.8, 132.9, 133.9, 134.6, 139.4, 154.3. MS (ESI+): *m*/*z* = 492.1. ESI-HR-MS calculated for C~31~H~33~N~3~OSi \[MH\]^+^: 492.2466, found: 492.2465.

### *N*-(2-(8,9-Dimethoxy-2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**7aba**) {#sec4.3.21}

Yield: 82% (1.02 g from 0.3 g of **1a**); a brown solid, mp 115--118 °C; *R~f~* = 0.56 (hexanes/EtOAc, 7:3 v/v); IR (KBr) ν~max~: 1674 (C=O), 3394 (N--H) cm^--1^.^1^H NMR (400 MHz, DMSO-*d*~6~): δ (ppm) = 2.57 (s, 2H), 2.83--2.95 (m, 2H), 3.21--3.36 (m, 2H), 3.66--3.72 (m, 1H), 3.80 (s, 7H), 3.89 (s, 3H), 3.97 (s, 3H), 4.04--4.17 (m, 2H), 6.41 (s, 1H), 6.51 (s, 1H), 6.71 (d, *J* = 19.7 Hz, 2H), 6.84 (s, 1H), 7.14 (s, 3H), 7.20--7.25 (m, 2H), 7.30--7.38 (m, 3H), 7.40--7.46 (m, 1H), 8.12 (d, *J* = 7.6 Hz, 1H); ^13^C NMR (100 MHz, DMSO-*d*~6~): δ (ppm) = 28.3, 29.0, 41.4, 41.9, 45.2, 56.1, 56.3, 101.8, 106.1, 109.3, 111.3, 111.4, 120.7, 121.5, 121.8, 122.6, 123.6, 123.8, 124.8, 124.9, 126.1, 126.3, 126.8, 128.8, 129.8, 131.5, 131.8, 135.2, 138.3, 147.7, 147.9, 148.1, 148.6, 154.6. MS (ESI+): *m*/*z* = 616.1. ESI-HR-MS calculated for C~38~H~37~N~3~O~5~ \[MH\]^+^: 616.2806, found: 616.2796.

### *N*-(2-(8-Phenyl-4,5-dihydrothieno\[2,3-*g*\]indolizin-7-yl)phenyl)-6,7-dihydrothieno\[3,2-*c*\]pyridine-5(4*H*)-carboxamide (**7aca**) {#sec4.3.22}

Yield: 84% (0.87 g from 0.3 g of **1a**); a yellow solid, mp 94--97 °C; *R~f~* = 0.60 (hexanes/EtOAc, 7:3 v/v); IR (KBr) ν~max~: 1669 (C=O), 3403 (N--H) cm^--1^.^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.61--2.70 (m, 2H), 2.93--3.00 (m, 1H), 3.06--3.13 (m, 1H), 3.34--3.41 (m, 1H), 3.47--3.53 (m, 1H), 3.74--3.80 (m, 1H), 3.92--4.10 (m, 3H), 6.61 (d, *J* = 5.1 Hz, 1H), 6.67 (s, 1H), 6.74 (s, 1H), 7.04 (d, *J* = 5.1 Hz, 1H), 7.11--7.25 (m, 6H), 7.30--7.36 (m, 3H), 7.42 (t, *J* = 7.3 Hz, 1H), 8.08 (d, *J* = 8.3 Hz,1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 24.7, 24.9, 41.5, 42.6, 44.2, 102.0, 120.8, 121.6, 122.7, 123.2, 123.2, 124.0, 124.7, 126.2, 126.3, 128.8, 129.7, 129.9, 130.2, 130.3, 131.4, 131.5, 133.6, 135.0, 138.1, 154.6. MS (ESI+): *m*/*z* = 508.2. ESI-HR-MS calculated for C~30~H~25~N~3~OS~2~ \[MH\]^+^: 508.1512, found: 508.1510.

### (*E*)-Methyl 3-(3,4-Dihydroisoquinolin-2(1*H*)-yl)acrylate (**8am**) {#sec4.3.23}

Yield: 83% (0.83 g from 0.29 g of **3m**); a yellow oil; *R~f~* = 0.68 (hexanes/EtOAc, 6:4 v/v); IR (CHCl~3~) ν~max~: 1674 (C=O) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.91 (t, *J* = 5.89 Hz, 2H), 3.50 (t, *J* = 5.84 Hz, 2H), 3.68 (s, 3H), 4.34 (s, 2H), 4.71 (d, *J* = 13 Hz, 1H), 7.10--7.22 (m, 4H), 7.61 (d, *J* = 13 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 50.7, 84.6, 126.3, 126.8, 127.0, 128.4, 127.7, 130.0, 134.4, 151.7, 170.2. MS (ESI+): *m*/*z* = 218.3. ESI-HR-MS calculated for C~13~H~15~NO~2~ \[MH\]^+^: 218.1176, found: 218.1171.

### Dimethyl 2-(3,4-Dihydroisoquinolin-2(1*H*)-yl)fumarate (**8an**) {#sec4.3.24}

Yield: 96% (0.572 g from 0.18 g of **3n**); a yellow oil; *R~f~* = 0.64 (hexanes/EtOAc, 6:4 v/v); IR (CHCl~3~) ν~max~: 1685 (C=O), 3449 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.91 (t, *J* = 5.8 Hz, 2H), 3.42 (t, *J* = 5.8 Hz, 2H), 3.65 (s, 3H), 3.97 (s, 3H), 4.31 (s, 2H), 4.78 (s, 1H), 7.08--7.15 (m, 2H), 7.19--7.22 (m, 2H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 29.0, 45.6, 48.7, 51.0, 53.1, 85.2, 126.3, 126.8, 127.2, 128.4, 131.9, 134.2, 154.2, 166.2, 168.2. MS (ESI+): *m*/*z* = 276.2. ESI-HR-MS calculated for C~15~H~17~NO~4~ \[MH\]^+^: 276.1230, found: 276.1229.

General Experimental Procedure for the Four-Component Reaction for the Synthesis of 1-Substituted-3-(2-(2-Phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)ureas **10** As Exemplified for **10aaaa** {#sec4.4}
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

To a stirred solution of isatin **1a** (2.04 mmol, 0.3 g) in toluene (15 mL) were added THIQ **5a** (4.08 mmol, 0.272 g), phenyl acetylene **3a** (2.04 mmol, 224 μL), aniline **9a** (2.04 mmol, 186 μL), and benzoic acid (20 mol %, 0.049 g), and the reaction mixture was heated at 90 °C under stirring for 20 h. On completion as evident from TLC analysis, the solvent was evaporated to obtain a residue that, upon column chromatography over silica gel using hexanes/EtOAc (80:20 v/v to 70:30 v/v) as eluent, gave 0.255 g (27%) of **10aaaa** as a white solid together with 0.463 g (45%) of **7aaa**.

### 1-Phenyl-3-(2-(2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)urea (**10aaaa**) {#sec4.4.1}

mp 187--190 °C; *R~f~* = 0.44 (hexanes/EtOAc, 7:3 v/v); IR (KBr) ν~max~: 1646 (C=O), 3441 (broad, N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.80--2.99 (m, 2H), 3.62--3.81 (m, 2H), 6.25 (s, 1H), 6.78 (s, 1H), 6.85 (s, 1H), 6.93--6.99 (m, 3H), 7.09--7.18 (m, 10H), 7.25--7.31 (m, 2H), 7.38--7.43 (m, 1H), 7.59 (d, *J* = 7.6 Hz, 1H), 8.24 (d, *J* = 8.3 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 29.4, 41.7, 103.5, 120.5, 121.7, 121.8, 122.6, 123.2, 124.4, 124.5, 125.0, 126.1, 126.4, 126.8, 127.4, 128.2, 128.6, 129.1, 129.4, 129.9, 131.0, 131.3, 132.0, 135.4, 137.6, 138.2, 153.0. MS (ESI+): *m*/*z* = 456.2. ESI-HR-MS calculated for C~31~H~25~N~3~O \[MH\]^+^: 456.2070, found: 456.2064.

### 1-(4-Chloro-2-(2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3-phenylurea (**10eaaa**) {#sec4.4.2}

Yield: 38% (0.38 g from 0.272 g of **5a**); a white solid, mp 117--120 °C; *R~f~* = 0.68 (hexanes/EtOAc, 7:3 v/v); IR (KBr) ν~max~: 1650 (C=O), 3457 (broad, N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.81--2.89 (m, 1H), 2.95--3.02 (m, 1H), 3.60--3.66 (m, 1H), 3.75--3.82 (m, 1H), 6.25 (s, 1H), 6.75 (s, 1H), 6.85 (s, 1H), 6.94--6.96 (m, 3H), 7.09--7.22 (m, 9H), 7.27--7.35 (m, 3H), 7.56 (d, *J* = 7.6 Hz, 1H), 8.22 (d, *J* = 8.9 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 29.2, 41.7, 103.6, 121.3, 121.9, 122.6, 123.0, 123.2, 124.7, 124.7, 126.3, 126.5, 126.6, 127.4, 127.8, 128.1, 128.7, 128.7, 129.4, 129.7, 130.8, 131.3, 131.6, 134.9, 136.8, 137.1, 152.7. MS (ESI+): *m*/*z* = 490.3. ESI-HR-MS calculated for C~31~H~24~ClN~3~O \[MH\]^+^: 490.1681, found: 490.1680.

### 1-Phenyl-3-(2-(2-(*p*-tolyl)-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)urea (**10aaba**) {#sec4.4.3}

Yield: 33% (0.32 g from 0.272 g of **5a**); a white solid, mp 241--243 °C; *R~f~* = 0.64 (hexanes/EtOAc, 7:3 v/v); IR (KBr) ν~max~: 1680 (C=O), 3305 (broad, N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.23 (s, 3H), 2.81--2.88 (m, 1H), 2.93--3.00 (m, 1H), 3.63--3.69 (m, 1H), 3.76--3.82 (m, 1H), 6.16 (s, 1H), 6.78 (s, 1H), 6.80 (s, 1H), 6.93--7.08 (m, 8H), 7.10--7.18 (m, 5H), 7.28--7.29 (m, 1H), 7.39--7.44 (m, 1H), 7.60 (d, *J* = 7.6 Hz, 1H), 8.24 (d, *J* = 8.3 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 21.1, 29.4, 41.7, 103.5, 120.4, 121.6, 121.7, 122.6, 123.2, 124.4, 124.7, 126.4, 126.7, 127.4, 128.2, 129.1, 129.4, 129.4, 129.9, 131.0, 131.3, 131.9, 132.4, 135.8, 137.6, 138.1, 152.9. MS (ESI+): *m*/*z* = 470.3. ESI-HR-MS calculated for C~32~H~27~N~3~O \[MH\]^+^: 470.2227, found: 470.2231.

### 1-(2-(2-Phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3-(*p*-tolyl)urea (**10aaab**) {#sec4.4.4}

Yield: 25% (0.24 g from 0.272 g of **5a**); a white solid, mp 179--182 °C; *R~f~* = 0.54 (hexanes/EtOAc, 8:2 v/v); IR (KBr) ν~max~: 1649 (C=O), 3339 (broad, N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.07 (s, 3H), 2.69--2.89 (m, 2H), 3.57--3.67 (m, 2H), 6.17 (s, 1H), 6.75--6.90 (m, 6H), 7.07--7.28 (m, 10H), 7.39 (t, *J* = 7.0 Hz, 1H), 7.58 (d, *J* = 7.4 Hz, 1H), 8.28 (d, *J* = 7.8 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 20.7, 29.3, 41.6, 103.5, 120.1, 121.5, 122.6, 123.0, 123.1, 124.4, 125.0, 126.0, 126.3, 126.8, 127.3, 128.1, 128.5, 129.1, 130.0, 130.1, 131.2, 132.0, 134.4, 135.1, 135.4, 138.2, 153.5. MS (ESI+): *m*/*z* = 470.2. ESI-HR-MS calculated for C~32~H~27~N~3~O \[MH\]^+^: 470.2227, found: 470.2219.

### 1-(4-Chlorophenyl)-3-(2-(2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)urea (**10aaac**) {#sec4.4.5}

Yield: 36% (0.359 g from 0.272 g of **5a**); a white solid, mp 195--198 °C; *R~f~* = 0.62 (hexanes/EtOAc, 8:2 v/v); IR (KBr) ν~max~: 1649 (C=O), 3339 (broad, N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.83--3.01 (m, 2H), 3.63--3.82 (m, 2H), 6.31 (s, 1H), 6.78 (s, 2H), 6.89 (d, *J* = 8.5 Hz, 2H), 7.05--7.16 (m, 10H), 7.25--7.28 (m, 2H), 7.38 (t, *J* = 7.4 Hz, 1H), 7.59 (d, *J* = 7.7 Hz, 1H), 8.14 (d, *J* = 8.2 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 29.4, 41.8, 103.3, 120.9, 122.1, 122.7, 122.8, 123.6, 124.3, 125.0, 126.1, 126.5, 127.5, 128.2, 128.9, 129.6, 130.0, 131.1, 131.4, 132.0, 135.2, 136.2, 137.8, 152.9. MS (ESI+): *m*/*z* = 490.2. ESI-HR-MS calculated for C~31~H~24~ClN~3~O \[MH\]^+^: 490.1681, found: 490.1679.

### 1-(3-Bromophenyl)-3-(2-(2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)urea (**10aaad**) {#sec4.4.6}

Yield: 37% (0.403 g from 0.272 g of **5a**); a white solid, mp 176--178 °C; *R~f~* = 0.62 (hexanes/EtOAc, 8:2 v/v); IR (KBr) ν~max~: 1683 (C=O), 3432 (broad, N--H) cm^--1^.^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.85--3.02 (m, 2H), 3.65--3.71 (m, 1H), 3.78--3.85 (m, 1H), 6.33 (s, 1H), 6.79 (s, 2H), 6.90--6.98 (m, 2H), 7.07--7.23 (m, 10H), 7.27--7.29 (m, 2H), 7.35--7.40 (m, 1H), 7.57 (d, *J* = 7.64 Hz, 1H), 8.11 (d, *J* = 8.16 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 29.3, 41.7, 110.3, 119.3, 120.9, 121.9, 122.6, 122.7, 123.5, 123.8, 124.9, 126.1, 126.4, 126.6, 126.9, 127.3, 128.1, 128.6, 128.9, 129.7, 130.3, 130.9, 131.4, 131.9, 135.2, 137.6, 139.1, 135.2, 137.6, 139.1, 152.4. MS (ESI+): *m*/*z* = 534.1. ESI-HR-MS calculated for C~31~H~24~BrN~3~O \[MH\]^+^: 534.1176, found: 534.1167.

### 1-(Isoquinolin-5-yl)-3-(2-(2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)urea (**10aaah**) {#sec4.4.7}

Yield: 35% (0.362 g from 0.272 g of **5a**); a white solid, mp 142--145 °C; *R~f~* = 0.52 (hexanes/EtOAc, 8:2 v/v); IR (KBr) ν~max~: 1671 (C=O), 3435 (broad, N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 3.00 (t, *J* = 6.3 Hz, 2H), 3.82--3.96 (m, 2H), 6.91 (s, 2H), 7.03 (t, *J* = 7.3 Hz, 1H), 7.12--7.19 (m, 5H), 7.27--7.34 (m, 4H), 7.37--7.41 (m, 2H), 7.46 (t, *J* = 8.1 Hz, 2H), 7.64 (d, *J* = 7.7 Hz, 1H), 8.10 (dd, *J*~1~ = 8.3 Hz, *J*~2~ = 1.4 Hz, 1H), 8.22 (d, *J* = 8.2 Hz, 1H), 8.37 (dd, *J*~1~ = 7.6 Hz, *J*~2~ = 0.9 Hz, 1H), 8.71 (dd, *J*~1~ = 4.2 Hz, *J*~2~ = 1.5 Hz, 1H), 8.81 (s, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 29.4, 42.0, 103.8, 115.3, 120.2, 121.2, 121.6, 121.9, 122.7, 123.3, 124.9, 125.3, 126.2, 126.4, 127.1, 127.4, 127.6, 128.2, 128.8, 129.2, 129.7, 131.2, 131.6, 132.0, 135.4, 135.6, 136.4, 137.9, 138.4, 147.9, 152.2. MS (ESI+): *m*/*z* = 507.4. ESI-HR-MS calculated for C~34~H~26~N~4~O \[MH\]^+^: 507.2179, found: 507.2175.

### 1-((3*s*,5*s*,7*s*)-Adamantan-1-yl)-3-(2-(2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)urea (**10aaan**) {#sec4.4.8}

Yield: 43% (0.451 g from 0.272 g of **5a**); a white solid, mp 142--144 °C; *R~f~* = 0.64 (hexanes/EtOAc, 8:2 v/v); IR (KBr) ν~max~: 1671 (C=O), 3452 (broad, N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.59 (s, 6H), 1.75--1.81 (m, 6H), 1.98 (s, 3H), 2.98--3.03 (m, 2H), 3.72--3.78 (m, 1H), 3.81--3.88 (m, 1H), 3.94 (s, 1H), 6.25 (s, 1H), 6.90 (s, 1H), 7.06 (dt, *J*~1~ = 7.5 Hz, *J*~2~ = 1 Hz, 1H), 7.14--7.24 (m, 6H), 7.26--7.31 (m, 3H), 7.36--7.40 (m, 1H), 7.63 (d, *J* = 7.6 Hz, 1H), 8.19 (d, *J* = 8.3 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 29.6, 36.4, 41.8, 42.2, 51.2, 103.4, 119.9, 120.6, 122.3, 124.1, 125.4, 126.2, 126.4, 126.6, 127.4, 128.2, 128.7, 129.1, 129.8, 131.1, 131.4, 131.8, 135.5, 138.8, 153.8. MS (ESI+): *m*/*z* = 514.4. ESI-HR-MS calculated for C~35~H~35~N~3~O \[MH\]^+^: 514.2853, found: 514.2847.

### 1-(*tert*-Butyl)-3-(2-(2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)urea (**10aaao**) {#sec4.4.9}

Yield: 21% (0.186 g from 0.272 g of **5a**); a white solid, mp 147--149 °C; *R~f~* = 0.63 (hexanes/EtOAc, 7:3 v/v); IR (KBr) ν~max~: 1662 (C=O), 3426 (broad, N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.19 (s, 9H), 2.98--3.05 (m, 2H), 3.73--3.79 (m, 1H), 3.83--3.89 (m, 1H), 3.97 (s, 1H), 6.19 (s, 1H), 6.89 (s, 1H), 7.07 (t, *J* = 7.5 Hz, 1H), 7.13--7.31 (m, 9H), 7.36--7.40 (m, 1H), 7.64 (d, *J* = 7.6 Hz, 1H), 8.16 (d, *J* = 8.2 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 29.2, 29.5, 103.4, 119.9, 120.7, 122.3, 122.7, 124.1, 125.4, 126.2, 126.5, 126.6, 127.5, 128.2, 128.8, 129.1, 129.8, 131.1, 131.2, 131.8, 135.6, 138.8, 154.0. MS (ESI+): *m*/*z* = 436.4. ESI-HR-MS calculated for C~29~H~29~N~3~O \[MH\]^+^: 436.2386, found: 436.2385.

### 6 {#sec4.4.10}

The spirooxindoles were isolated by arresting the reaction as described for the preparation of **7**, in 4 h.

### 2′-Phenyl-6′,10*b*′-dihydro-5′*H*-spiro\[indoline-3,3′-pyrrolo\[2,1-*a*\]isoquinolin\]-2-one (**6a**) {#sec4.4.11}

Yield: 49% (0.364 g from 0.3 g of **1a**); a white solid, mp 145--146 °C; *R~f~* = 0.68 (hexanes/EtOAc, 6:4 v/v); IR (KBr) ν~max~: 1736 (C=O), 3453 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.66--2.72 (m, 3H), 3.19--3.28 (m, 1H), 5.55 (s, 1H), 6.58 (d, *J* = 7.34 Hz, 1H), 6.78 (dt, *J*~1~ = 7.53 Hz, *J*~2~ = 0.75 Hz, 1H), 6.86 (d, *J* = 7.76 Hz, 1H), 6.9 (d, *J* = 2.32 Hz, 1H), 7.02--7.05 (m, 2H), 7.09--7.25 (m, 7H), 7.28--7.31 (m, 1H), 8.57 (s, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 28.3, 41.5, 64.8, 79.2, 110.5, 122.8, 124.4, 126.2, 126.3, 126.5, 127.1, 127.9, 128.4, 128.7, 129.0, 129.5, 130.0, 133.4, 135.5, 139.0, 141.1, 142.7, 179.5. MS (ESI+): *m*/*z* = 365.2. ESI-HR-MS calculated for C~25~H~20~N~2~O \[MH\]^+^: 365.1648, found: 365.1649.

### 5-Bromo-2′-phenyl-6′,10*b*′-dihydro-5′*H*-spiro\[indoline-3,3′-pyrrolo\[2,1-*a*\]isoquinolin\]-2-one (**6b**) {#sec4.4.12}

Yield: 35% (0.205 g from 0.3 g of **1f**); a brown solid, mp 168--170 °C; *R~f~* = 0.56 (hexanes/EtOAc, 8:2 v/v); IR (CHCl~3~) ν~max~: 1726 (C=O), 3402 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.62--2.72 (m, 3H), 3.21--3.26 (m, 1H), 5.50 (s, 1H), 6.65 (d, *J* = 1.77 Hz, 1H), 6.74 (d, *J* = 8.25 Hz, 1H), 6.93 (d, *J* = 2.2 Hz, 1H), 7.03--7.06 (m, 2H), 7.13--7.16 (m, 5H), 7.27--7.29 (m, 3H), 8.60 (s, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 28.4, 41.5, 64.89, 79.16, 111.9, 115.8, 124.3, 126.3, 126.4, 126.5, 126.9, 128.3, 128.7, 128.8, 129.5, 130.6, 131.4, 132.5, 133.2, 135.3, 138.9, 140.1, 142.6, 178.9. MS (ESI+): *m*/*z* = 443.2. ESI-HR-MS calculated for C~25~H~19~BrN~2~O \[MH\]^+^: 443.0754, found: 443.0754.

Experimental Procedure for the Synthesis of 1-Substituted-3-(2-(2-Phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)ureas **10** from **6a** As Exemplified for **10aaal** {#sec4.5}
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

To a stirred solution of spirooxindole **6a** (0.275 mmol, 0.1 g) in toluene (5 mL) was added amine **9l** (0.275 mmol, 20 μL), and the reaction mixture was heated at 90 °C for 14 h. On completion, the solvent was evaporated to obtain a residue that was directly purified by column chromatography over silica gel using hexanes/EtOAc (80:20, v/v) as eluent to obtain 0.11 g (86%) of **10aaal** as a white solid.

### 1-Benzyl-3-(2-(2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)urea (**10aaal**) {#sec4.5.1}

mp 177--179 °C; *R~f~* = 0.6 (hexanes/EtOAc, 8:2 v/v); IR (CHCl~3~) ν~max~: 1724 (C=O), 3373 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.85--3.00 (m, 2H), 3.63--3.69 (m, 1H), 3.78--3.85 (m, 1H), 4.15 (d, *J* = 5.36 Hz, 2H), 4.53 (s, 1H), 6.4 (s, 1H), 6.84 (s, 1H), 7.09--7.12 (m, 4H), 7.16--7.22 (m, 9H), 7.26--7.30 (m, 2H), 7.37--7.41 (m, 1H), 7.60 (d, *J* = 7.73 Hz, 1H), 8.17 (d, *J* = 8.1 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 29.4, 41.8, 44.5, 103.4, 120.5, 121.3, 122.7, 122.9, 124.2, 125.1, 126.1, 126.4, 126.6, 127.4, 127.4, 127.5, 128.2, 128.7, 128.8, 129.1, 129.8, 131.1, 131.5, 131.9, 135.5, 138.4, 154.9. MS (ESI+): *m*/*z* = 470.3. ESI-HR-MS calculated for C~32~H~27~N~3~O \[MH\]^+^: 470.2227, found: 470.2228.

### 1-Cyclopropyl-3-(2-(2-phenyl-5,6-dihydropyrrolo\[2,1-a\]isoquinolin-3-yl)phenyl)urea (**10aaap**) {#sec4.5.2}

Yield: 87% (0.1 g from 0.1 g of **6a**); a yellow oil; *R~f~* = 0.54 (hexanes/EtOAc, 7:3 v/v); IR (CHCl~3~) ν~max~: 1642 (C=O), 3374 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.85--3.00 (m, 2H), 3.63--3.69 (m, 1H), 3.78--3.85 (m, 1H), 4.15 (d, *J* = 5.36 Hz, 2H), 4.53 (s, 1H), 6.4 (s, 1H), 6.84 (s, 1H), 7.09--7.12 (m, 4H), 7.16--7.25 (m, 10H), 7.26--7.30 (m, 2H), 7.37--7.41 (m, 1H), 7.60 (d, *J* = 7.73 Hz, 1H), 8.17 (d, *J* = 8.1 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 29.4, 41.8, 44.5, 103.4, 120.5, 121.3, 122.7, 122.9, 124.2, 125.1, 126.1, 126.4, 126.6, 127.4, 127.4, 127.5, 128.2, 128.7, 128.8, 129.1, 129.8, 131.1, 131.5, 131.9, 135.5, 138.4, 154.9. MS (ESI+): *m*/*z* = 420.4. ESI-HR-MS calculated for C~28~H~25~N~3~O \[MH\]^+^: 420.2070, found: 420.2068.

### *N*-(2-(2-Phenyl-5,6-dihydropyrrolo\[2,1-a\]isoquinolin-3-yl)phenyl)pyrrolidine-1-carboxamide (**10aaaq**) {#sec4.5.3}

Yield: 79% (0.094 g from 0.1 g of **6a**); a yellow solid, mp 101--102 °C; *R~f~* = 0.52 (hexanes/EtOAc, 6:4 v/v); IR (CHCl~3~) ν~max~: 1646 (C=O), 3392 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.74--1.76 (m, 4H), 2.96--3.05 (m, 6H), 3.69--3.75 (m, 1H), 3.82--3.89 (m, 1H), 6.47 (s, 1H), 6.92 (s, 1H), 7.09--7.22 (m, 7H), 7.28--7.31 (m, 4H), 7.39--7.44 (m, 1H), 7.64 (d, *J* = 7.6 Hz, 1H), 8.26 (d, *J* = 8.3 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 25.5, 29.5, 29.8, 41.8, 45.4, 103.1, 120.0, 120.9, 122.3, 122.7, 123.9, 125.3, 126.1, 126.4, 127.4, 128.2, 128.7, 129.2, 129.9, 131.1, 131.5, 135.2, 138.8, 153.6. MS (ESI+): *m*/*z* = 434.4. ESI-HR-MS calculated for C~29~H~27~N~3~O \[MH\]^+^: 434.2227, found: 434.2225.

Experimental Procedure for Transformation of **6a** to Aniline **11** {#sec4.6}
---------------------------------------------------------------------

To a stirred solution of compound **6a** (0.82 mmol) in DMF was added Cs~2~CO~3~ (0.268 g, 0.82 mmol) in one portion at room temperature, and the reaction was continued for 24 h. After completion, the reaction mixture was extracted with EtOAc (50 mL × 2) and water (30 mL). The organic layers were pooled, dried over anhydrous Na~2~SO~4~, and concentrated under reduced pressure to obtain a residue, which was purified by column chromatography over silica gel using hexanes/EtOAc (80:20 v/v to 70:30 v/v) as eluent to obtain **11** (0.257 g, 93%) as a pale yellow oil.

2-(2-Phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)aniline (**11**) {#sec4.7}
--------------------------------------------------------------------------

Yellow oil; *R~f~* = 0.53 (hexanes/EtOAc, 8:2 v/v); IR (CHCl~3~) ν~max~: 3405 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.98 (t, *J* = 6.3 Hz, 2H), 3.64 (s, 2H), 3.75--3.85 (m, 2H), 6.71--6.79 (m, 2H), 6.87 (s, 1H), 7.07--7.27 (m, 9H), 7.30--7.32 (m, 1H), 7.61 (d, *J* = 7.6 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 29.5, 41.6, 103.3, 115.5, 117.8, 118.6, 122.5, 123.4, 125.5, 126.0, 126.7, 126.7, 127.3, 128.1, 128.4, 129.4, 129.8, 130.7, 131.0, 132.4, 136.1, 146.1. MS (ESI+): *m*/*z* = 337.3. ESI-HR-MS calculated for C~24~H~20~N~2~ \[MH\]^+^: 337.1699, found: 337.1701.

Experimental Procedure for the Oxidative Thiocyanation of **7aaa** {#sec4.8}
------------------------------------------------------------------

To a stirred solution of **7aaa** (0.4 mmol, 0.2 g) in methanol (10 mL) were added ammonium thiocyanate (0.485 mmol, 0.037 g) and ceric ammonium nitrate (1.0 mmol, 0.553 g) at room temperature, and the reaction was continued for 6 h. After completion of the reaction (as monitored by TLC), the solvent was evaporated, and the reaction was quenched with water (50 mL), and the mixture was extracted with EtOAc (50 mL × 2). The combined organic layer was dried over anhydrous Na~2~SO~4~ and concentrated under reduced pressure to obtain the crude product, which was purified by column chromatography over silica gel using hexanes/EtOAc (60:40, v/v) as eluent to obtain 0.198 g (89%) of product **13** as a yellow solid.

### *N*-(2-(2-Phenyl-1-thiocyanato-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**13**) {#sec4.8.1}

Mp 86--89 °C; *R~f~* = 0.42 (hexanes/EtOAc, 7:3 v/v); IR (KBr) ν~max~: 1670 (C=O), 3443 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.75--2.78 (m, 2H), 2.85--3.04 (m, 2H), 3.39 (t, *J* = 5.9 Hz, 2H), 3.68--3.75 (m, 1H), 3.87--3.93 (m, 1H), 4.28--4.39 (m, 2H), 6.32 (s, 1H), 7.05--7.15 (m, 6H), 7.23--7.35 (m, 7H), 7.37--7.46 (m, 2H), 7.97 (d, *J* = 8.2 Hz, 1H), 8.49 (d, *J* = 7.8 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 28.7, 29.7, 41.7, 42.5, 45.4, 102.7, 118.4, 119.5, 120.4, 121.2, 122.6, 124.8, 125.8, 126.3, 126.4, 126.5, 126.7, 127.4, 128.2, 128.4, 129.0, 130.0, 131.1, 131.4, 131.5, 133.2, 134.9, 135.8, 138.6, 154.5. MS (ESI+): *m*/*z* = 553.2. ESI-HR-MS calculated for C~35~H~28~N~4~OS \[MH\]^+^: 553.2056, found: 553.2059.

Experimental Procedure for the Oxidative Bromination of **7aaa** {#sec4.9}
----------------------------------------------------------------

To a stirred solution of **7aaa** (0.5 mmol, 0.25 g) in DMF (15 mL) was added NBS (0.6 mmol, 0.107 g) in portions at 0 °C, and the reaction was continued at room temperature for 12 h. After completion of the reaction (as monitored by TLC), the reaction mixture was extracted with EtOAc (50 mL × 2) and water (30 mL). The combined organic layer was dried over anhydrous Na~2~SO~4~ and concentrated under reduced pressure to obtain a crude product, which was purified by column chromatography over silica gel using hexanes/EtOAc (60:40, v/v) as eluent to obtain 0.253 g (87%) of product **14** as a white solid.

### *N*-(2-(1-Bromo-2-phenyl-5,6-dihydropyrrolo\[2,1-*a*\]isoquinolin-3-yl)phenyl)-3,4-dihydroisoquinoline-2(1*H*)-carboxamide (**14**) {#sec4.9.1}

Yield: 87% (0.253 g from 0.25 g of **7aaa**); a white solid, mp 132--135 °C; *R~f~* = 0.67 (hexanes/EtOAc, 6:4 v/v); IR (KBr) ν~max~: 1655 (C=O), 3402 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.76 (t, J = 5.8 Hz, 2H), 2.81--2.88 (m, 1H), 2.94--3.00 (m, 1H), 3.37--3.46 (m, 2H), 3.67--3.73 (m, 1H), 3.83--3.89 (m, 1H), 4.25--4.34 (m, 2H), 6.41 (s, 1H), 7.03--7.14 (m, 6H), 7.19--7.21 (m, 3H), 7.29--7.39 (m, 6H), 7.96 (d, *J* = 8.2 Hz, 1H), 8.51 (d, *J* = 7.9 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 28.8, 30.1, 41.5, 42.5, 45.8, 94.1, 120.8, 121.6, 122.8, 124.2, 126.4, 126.6, 126.9, 127.1, 127.2, 128.2, 128.3, 128.5, 129.7, 130.0, 131.8, 132.6, 133.0, 133.1, 134.9, 138.2, 154.6. MS (ESI+): *m*/*z* = 574.7. ESI-HR-MS calculated for C~34~H~28~BrN~3~O \[MH\]^+^: 574.1489, found: 574.1490.

Experimental Procedure for the Basic Hydrolysis of **7aaa** {#sec4.10}
-----------------------------------------------------------

To a solution of **7aaa** (0.579 mmol, 0.287 g) in 1,4-dioxane (15 mL) was added aq KOH solution (0.162 g, 2.895 mmol dissolved in 10 mL of water), and the mixture was heated at 90 °C for 24 h. The reaction mixture was allowed to cool to room temperature and extracted with EtOAc (50 mL × 2) and water (20 mL). Organic layers were combined, dried over anhydrous Na~2~SO~4~, and concentrated under reduced pressure to furnish the crude product, which was purified by column chromatography over silica gel using hexanes/EtOAc (80:20 v/v to 70:30 v/v) as eluent to furnish 0.113 g (58%) of aniline **11** together with 0.1 g of unreacted starting material **7aaa**.

Experimental Procedure for the Reaction of **7aaa** with Lawesson's Reagent {#sec4.11}
---------------------------------------------------------------------------

In a 30 mL microwave vial containing **7aaa** (0.108 mmol, 0.05 g) in 5 mL of THF, Lawesson's reagent (0.13 mmol, 0.052 g) was added and irradiated at 120 °C for 2 h. After completion of the reaction (as monitored by TLC), the reaction mixture was extracted with EtOAc (50 mL × 2) and water (30 mL). The combined organic layer was dried over anhydrous Na~2~SO~4~ and concentrated under reduced pressure to obtain the crude product, which was purified by column chromatography over silica gel using hexanes/EtOAc (80:20 v/v to 70:30 v/v) as eluent to obtain 0.032 g (94%) of aniline **11**.

Experimental Procedure for the Synthesis of Thiourea **15a** from Aniline **11** {#sec4.12}
--------------------------------------------------------------------------------

To a stirred solution of aniline **11** (0.89 mmol, 0.3 g) in MeOH (15 mL) was added 3-chlorophenyl isothiocyanate (0.89 mmol, 0.117 mL) at room temperature, and the reaction was continued for 24 h. After completion, the reaction mixture was extracted with EtOAc (50 mL × 2) and water (30 mL). The combined organic layer was dried over anhydrous Na~2~SO~4~ and concentrated under reduced pressure to afford a residue, which was purified by column chromatography over silica gel using hexanes/EtOAc (80:20, v/v) as eluent to yield 0.248 g (55%) of thiourea **15a** as a brown solid.

### 1-(3-Chlorophenyl)-3-(2-(2-phenyl-5,6-dihydropyrrolo\[2,1-a\]isoquinolin-3-yl)phenyl)thiourea (**15a**) {#sec4.12.1}

Mp 159--161 °C; *R~f~* = 0.6 (hexanes/EtOAc, 8:2 v/v);); IR (KBr) ν~max~: 1521 (C=S), 3396 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.95--2.98 (m, 2H), 3.79 (t, *J* = 6.7 Hz, 2H), 6.75--6.76 (m, 2H), 6.96 (t, *J* = 1.7 Hz, 1H), 7.02--7.18 (m, 9H), 7.27--7.37 (m, 2H), 7.40--7.43 (m, 2H), 7.47--7.53 (m, 2H), 7.60 (d, *J* = 7.6 Hz, 1H), 8.12 (d, *J* = 8.2 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) =29.5, 42.0, 103.6, 122.7, 123.1, 124.5, 124.6, 125.2, 126.0, 126.1, 126.4, 126.6, 126.7, 127.4, 127.4, 127.4, 128.2, 128.6, 129.1, 129.4, 130.9, 131.1, 131.3, 132.4, 135.2, 135.5, 137.2, 137.8, 179.3. MS (ESI+): *m*/*z* = 506.3. ESI-HR-MS calculated for C~31~H~24~N~3~S \[MH\]^+^: 506.1452, found: 506.1447.

General Experimental Procedure for the Synthesis of **16** as Exemplified for **16a** {#sec4.13}
-------------------------------------------------------------------------------------

In a sealed tube containing spirooxindole **6a** (0.18 g, 0.49 mmol) was added POCl~3~ (462 μL, 4.93 mmol), and the mixture was heated at 90 °C for 24 h under stirring. On completion of the reaction (as monitored by TLC), the reaction mixture was cooled to room temperature and neutralized by adding saturated aqueous NaHCO~3~ solution and extracted with EtOAc (50 mL × 2). The organic layers were pooled, dried over anhydrous Na~2~SO~4~, and evaporated under vacuum to obtain a residue, which was purified by column chromatography over silica gel using CHCl~3~/MeOH (95:05, v/v) as eluent to afford 0.126 g (74%) of **16a** as an orange solid.

### 8-Phenyl-1,2-dihydroindolo\[3′,2′:5,6\]pyrido\[2,1-*a*\]isoquinoline (**16a**) {#sec4.13.1}

mp 202--205 °C; *R~f~* = 0.6 (CHCl~3~/MeOH, 9:1 v/v); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 3.27 (t, *J* = 6.6 Hz, 2H), 5.09 (t, *J* = 6.5 Hz, 2H), 6.99--7.03 (m, 1H), 7.30 (s, 1H), 7.38--7.48 (m, 4H), 7.58--7.67 (m, 4H), 7.76--7.78 (m, 2H), 7.80--7.82 (d, J = 8.1 Hz, 1H), 7.92--7.94 (m, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 27.9, 43.7, 106.9, 117.9, 119.0, 121.7, 122.2, 123.2, 126.0, 127.9, 128.1, 128.5, 128.7, 129.0, 129.3, 129.4, 130.5, 134.9, 138.4, 138.6, 145.9, 153.8, 153.9. MS (ESI+): *m*/*z* = 347.3. ESI-HR-MS calculated for C~25~H~18~N~2~ \[MH\]^+^: 347.1543, found: 347.1539.

### 10-Bromo-8-phenyl-1,2-dihydroindolo\[3′,2′:5,6\]pyrido\[2,1-*a*\]isoquinoline (**16b**) {#sec4.13.2}

Yield: 84% (0.178 g from 0.222 g of **6b**); a brown solid, mp 256--260 °C; *R~f~* = 0.5 (CHCl~3~/MeOH, 9:1 v/v). ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 3.28 (t, *J* = 6.4 Hz, 2H), 5.07 (t, *J* = 6.3 Hz, 2H), 7.35 (s, 1H), 7.38--7.40 (m, 1H), 7.43--7.47 (m, 2H), 7.53 (dd, *J*~1~ = 8.6 Hz, *J*~2~ = 1.7 Hz, 1H), 7.62--7.69 (m, 4H), 7.74--7.75 (m, 3H), 7.94 (d, *J* = 7.2 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 27.9, 44.1, 107.7, 111.9, 119.2, 120.4, 124.6, 124.7, 126.2, 128.2, 128.6, 128.6, 129.0, 129.2, 129.8, 130.6, 131.0, 135.0, 137.9, 139.5, 147.3, 151.5, 153.4. MS (ESI+): *m*/*z* = 425.4. ESI-HR-MS calculated for C~25~H~17~BrN~2~ \[MH\]^+^: 425.0648, found: 425.0648.

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acsomega.9b03546](https://pubs.acs.org/doi/10.1021/acsomega.9b03546?goto=supporting-info).The copies of ^1^H NMR, ^13^C NMR, and HRMS spectra and the details of the X-ray crystallographic analysis of **7eaa** ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b03546/suppl_file/ao9b03546_si_001.pdf))X-ray crystallographic data of **7eaa** ([CIF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b03546/suppl_file/ao9b03546_si_002.cif))
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